Results 161 to 170 of about 564,426 (377)

Epidemiology of non-Hodgkin lymphoma in connecticut 1935-1988 [PDF]

, 1992
Tongzhang Zheng, Susan T. Mayne, Peter Boyle, Theodore R. Holford, Wen Liang Liu, John Flannery   +5 more
openalex   +1 more source

PD‐L1 Expression is Mediated by microRNA Processing, Wnt/β‐Catenin Signaling, and Chemotherapy in Wilms Tumor

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Inhibition of immune checkpoint proteins is effective in adult cancers but has shown limited efficacy in pediatric cancers. While factors regulating expression of immune checkpoint proteins such as PD‐L1 are well documented in adult cancers, their regulation is poorly understood in pediatric cancers.
Patricia D. B. Tiburcio, Kavita Desai, Austin Warne, Arash Nabbi, Serena Zhou, Sean D. Reiff, Matthew E. Campbell, James F. Amatruda, Kenneth S. Chen   +8 more
wiley   +1 more source

Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma [PDF]

, 1992
Gianluca Gaïdano, R. Hauptschein, NZ Parsa, Kenneth Offit, PH Rao, G Lenoir, DM Knowles, RS Chaganti, Riccardo Dalla‐Favera   +8 more
openalex   +1 more source

Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High‐Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background CHIPS (Childhood Hodgkin International Prognostic Score), a predictive score for event‐free‐survival (EFS), was originally developed using factors presenting at diagnosis in patients with intermediate‐risk Hodgkin lymphoma (HL).
Jennifer A. Belsky, Lindsay A. Renfro, Frank G. Keller, David C. Hodgson, Angela Punnett, Kathleen McCarten, Steve Y. Cho, Yue Wu, Kara M. Kelly, Sharon M. Castellino, Cindy L. Schwartz   +10 more
wiley   +1 more source

Hodgkin Lymphoma [PDF]

Journal of the National Comprehensive Cancer Network, 2011
Richard T, Hoppe, Ranjana H, Advani, Weiyun Z, Ai, Richard F, Ambinder, Celeste M, Bello, Philip J, Bierman, Kristie A, Blum, Bouthaina, Dabaja, Ysabel, Duron, Andres, Forero, Leo I, Gordon, Francisco J, Hernandez-Ilizaliturri, Ephraim P, Hochberg, David G, Maloney, David, Mansur, Peter M, Mauch, Monika, Metzger, Joseph O, Moore, David, Morgan, Craig H, Moskowitz, Matthew, Poppe, Barbara, Pro, Lawrence, Weiss, Jane N, Winter, Joachim, Yahalom   +24 more
openaire   +2 more sources

Novel Findings in Pediatric and Adolescent Patients With Cancer and a Germline SMARCA4 Variant

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction SMARCA4 is a known susceptibility gene for malignant rhabdoid tumors (MRT) in children and small cell carcinoma of the ovary hypercalcemic type (SCCOHT) in young females and women. Recently, a novel association between germline SMARCA4 variants and predisposition to neuroblastoma was proposed.
Nienke van Engelen, Ronald. R. de Krijger, Michelle M. Kleisman, Lennart. A. Kester, Saskia M. J. Hopman, Mariette E. G. Kranendonk, Marijn A. Vermeulen, Carli Tops, Seok‐Young Kim, Hans Clevers, Kornelia Neveling, Roland. P. Kuiper, Marjolijn C. J. Jongmans   +12 more
wiley   +1 more source

Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia [PDF]

, 1992
Luca Baldini, Lilla Cro, Rossella Calori, Lucia Nobili, Ilaria Silvestris, Maiolo At   +5 more
openalex   +1 more source

Circulating Tumor DNA in Pediatric Mature B‐Cell Non‐Hodgkin Lymphoma for Genotyping and Minimal Disease Monitoring

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Early detection of treatment failure in pediatric patients with mature B‐cell non‐Hodgkin lymphoma (NHL) could improve treatment stratification. Analysis of circulating tumor DNA (ctDNA) has been established as a biomarker in adult patients with mature B‐cell NHL (B‐NHL); however, data on ctDNA in pediatric mature B‐NHL are lacking.
Jana Werner, Christine Damm‐Welk, Marius Rohde, Patrick Hundsdörfer, Simon Vieth, Axel Karow, Anke Barnbrock, Wolfram Klapper, Julia Richter, Carla Koslowski, Luisa Kruppa, Malik Alawi, Amelie Alfert, Birgit Burkhardt, Wilhelm Wößmann, Fabian Knörr   +15 more
wiley   +1 more source

Primary Bone Marrow Classical Hodgkin Lymphoma in HIV- Negative Population: Aggressive but Amenable

Mediterranean Journal of Hematology and Infectious Diseases, 2014
Classical Hodgkin Lymphoma has distinct clinopathological features and good response to treatment in most cases. Primary bone marrow limited Hodgkin Lymphoma is uncommon and primarily described in HIV positive patients.
Bhagirathbhai R Dholaria, Daisy Alapat, Daisy Alapat, Konstantinos Arnaoutakis, Konstantinos Arnaoutakis   +4 more
doaj  

Primary Intestinal Hodgkin’s Lymphoma associated with Intussusception and Cholelithiasis

, 1970
MM Haque, AB Siddique, SM Badruddoza, MA Hye Manik   +3 more
openalex   +2 more sources